June 25, 2021
Dr. Poon, CEO of QuaCell Biotechnology, Co., Ltd. was honored to be elected Associate Editor of RE: GEN Open
（Source: Photo taken by Quacell media specialist）
JUN.25,2021/ QUACELL NEWSROOM/-QuaCell Biotechnology, Co., Ltd. Dr FAI POON was honoured to be selected as associate editor.
Thanks to Re: Gen Open for recognizing Dr Poon's work and inviting Dr Poon to become the Associate Editor of Re: Gen Open.
Re: Gen Open is a publishing specialist by Mary Ann Liebert, Inc. An open-access journal that combines global media with peer reviews on genetic engineering, biotechnology news (GEN) and science and so on, provides scientifically rigorous research. All biology-related industry practitioners can gain an unprecedented publishing experience from this platform: first-class author service, fast and peer review, and international exposure on industry-leading media platforms.
Re: GEN Open is dedicated to delivering open access advances in all aspects of basic and translational biomedical research, organized into the following core areas:
• Basic Biomedical Research
• Translational Biomedical Research
• Drug Development
• Cancer Research
• Regenerative Medicine
• Cell and Gene Therapy
• Infectious Disease
• Synthetic and Systems Biology
We hope that readers from related industries can participate in the journal submission https://home.liebertpub.com/regen which to accelerate the flow of information in the biological industry and maximize the knowledge gained from the discussion. As associate editors, we are more obligated to encourage more scholars to join, so that more excellent works can be displayed on this platform for scholars to learn from each other.
Drug Master Files are available for the QuaCell® CHO cell culture mediums, facilitating applications for antibody drugs
QuaCell Biotechnology launched its Innovation Research Center in Guangzhou